Abstract | BACKGROUND: MATERIALS AND METHODS: RESULTS: CONCLUSIONS: These results indicate that these peptide hormones' anticancer effects are specific. Furthermore, they have very potent effects of eliminating up to 97% of prostate cancer cells within 24 h of treatment.
|
Authors | B A Vesely, A A Alli, S J Song, W R Gower Jr, J Sanchez-Ramos, D L Vesely |
Journal | European journal of clinical investigation
(Eur J Clin Invest)
Vol. 35
Issue 11
Pg. 700-10
(Nov 2005)
ISSN: 0014-2972 [Print] England |
PMID | 16269020
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Antineoplastic Agents
- DNA, Neoplasm
- Natriuretic Peptides
- Peptide Fragments
- Protein Precursors
- atrial natriuretic factor precursor (79-98)
- atrial natriuretic factor prohormone (31-67)
- Natriuretic Peptide, Brain
- Natriuretic Peptide, C-Type
- Atrial Natriuretic Factor
- Guanylate Cyclase
- Receptors, Atrial Natriuretic Factor
- atrial natriuretic factor receptor A
- atrial natriuretic factor receptor B
|
Topics |
- Adenocarcinoma
(drug therapy)
- Antineoplastic Agents
(therapeutic use)
- Atrial Natriuretic Factor
(therapeutic use)
- Cell Count
- Cell Line, Tumor
- DNA, Neoplasm
(analysis)
- Dose-Response Relationship, Drug
- Guanylate Cyclase
(analysis)
- Humans
- Male
- Natriuretic Peptide, Brain
- Natriuretic Peptide, C-Type
- Natriuretic Peptides
(therapeutic use)
- Peptide Fragments
(therapeutic use)
- Prostatic Neoplasms
(drug therapy)
- Protein Precursors
(therapeutic use)
- Receptors, Atrial Natriuretic Factor
(analysis)
|